<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04111042</url>
  </required_header>
  <id_info>
    <org_study_id>TAULI-STENT</org_study_id>
    <nct_id>NCT04111042</nct_id>
  </id_info>
  <brief_title>Long-term Outcomes of Colonic Stent as a &quot;Bridge to Surgery&quot; for Malignant Large-bowel Obstruction</brief_title>
  <official_title>Long-term Outcomes of Colonic Stent as a &quot;Bridge to Surgery&quot; for Malignant Large-bowel Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xavier Serra-Aracil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anna Pallisera-Lloveras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of long-term outcomes of colonic stent as a &quot;bridge to surgery&quot; for malignant&#xD;
      large-bowel obstruction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective observational with retrospective analisis study of patients with left-sided&#xD;
      malignant colonic obstruction undergoing stenting between April 2006 and April 2018 in Parc&#xD;
      Tauli University Hospital. We assessed all patients with intent-to-treat and per protocol&#xD;
      analyses in postoperative and long-term follow-up variables.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">August 2019</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>long-term outcomes</measure>
    <time_frame>2 years</time_frame>
    <description>survival rates</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anastomotic leak</measure>
    <time_frame>30 days</time_frame>
    <description>surgery</description>
  </secondary_outcome>
  <enrollment type="Actual">117</enrollment>
  <condition>Stent Occlusion</condition>
  <condition>Long-term Oncologic Results</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stenting</intervention_name>
    <description>stenting procedure in patients diagnosed malignant large bowel occlusion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        : patient demographics, physiological status according to the American Society of&#xD;
        Anesthesiologist (ASA) score, tumor characteristics and localization, type of surgery,&#xD;
        surgical team, stoma formation rate, perioperative morbidity and mortality, tumor stage&#xD;
        according to the International Union Against Cancer (UICC)-TNM Classification of Malignant&#xD;
        Tumors published by the National Comprehensive Cancer Network (7th edition), administration&#xD;
        of adjuvant treatment, local and distant disease recurrence based on CT imaging (and&#xD;
        histological tissue if possible), disease-free survival and overall survival.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged over 18 years diagnosed with complete malignant colonic obstruction&#xD;
             confirmed by CT.&#xD;
&#xD;
          -  Elective surgery.&#xD;
&#xD;
          -  Location in transverse, left or sigmoid colon.&#xD;
&#xD;
          -  Patients who signed the informed consent documentation and agreed to undergo the&#xD;
             procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Benign pathology and palliative treatment.&#xD;
&#xD;
          -  Unresectable lesion (intraoperative), severe ischemia or cecal perforation, fecal or&#xD;
             advanced purulent peritonitis, emergency surgery.&#xD;
&#xD;
          -  Previous chemotherapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laura Mora LÃ³pez</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 29, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Laura Mora-Lopez</investigator_full_name>
    <investigator_title>DR</investigator_title>
  </responsible_party>
  <keyword>Malignant colonic obstruction</keyword>
  <keyword>self-expandable metallic stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There's no sharing plan because the study has finished the recruited time</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

